• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Briefing Information for the January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee

 
Please note that the Briefing Material below may include references to the originally scheduled Drug Safety and Risk Management Advisory Committee meeting which was to take place on October 29-30, 2012.  This originally scheduled meeting was postponed and rescheduled for January 24-25, 2013, due to unanticipated weather conditions caused by Hurricane Sandy.
 
 
Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance
 
 
FDA
 
Disclaimer
 
Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. § 552).
  
FDA Briefing Information for the January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee (PDF – 10.69MB)
 
Addendum to the FDA Briefing Information for the January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee (PDF – 18KB)
 
 
Generic Pharmaceutical Association (GPhA)
 
Disclaimer
 
The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.
 
GPhA Briefing Information for the January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee (PDF – 664KB)